American Society of Hirudotherapy

Leech Saposin-Like Peptide

Saposin-like lipid-binding peptide identified in leech salivary transcriptome — putative membrane-active component.

Preclinical / mechanisticLast updated: 2026-05-26 · Reviewed by ASH Editorial Board
Molecular weight of Leech Saposin-Like Peptide compared with other characterized leech-derived compoundsHementerin80 kDaHementin80 kDaHementin-Like Protein (HLP-1)80 kDaLeech Collagenase70 kDaHaemadipsa yanyuanensis Progr…70 kDaLeech Apyrase67 kDaCalin65 kDaHyaluronidase60 kDaAntithrombin III binding prot…58 kDaCollagenolytic Fibrinolysin55 kDaLeech Thrombospondin-Like Pro…50 kDaLeech Saposin-Like Peptide8 kDa
Molecular weight (kilodaltons) of Leech Saposin-Like Peptide (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic
Page type
Compound profile
Evidence type
Saposin-like lipid-binding peptide identified in leech salivary transcriptome — putative membrane-active component.
Evidence level
Mechanistic discussion
Drug vs leech
Purified natural compound

Clinical translation limit

This peptide is identified at sequence level only. Hypothesized membrane-active function is NOT biochemically verified. No FDA-approved derivative exists.

Molecular Profile

Category
Other
Evidence tier
Preclinical
Molecular weight
8,000 Da
Source species
Hirudo medicinalis
Discovered
2018
Leech Saposin-Like Peptide molecular structure

Biological Targets

  • lipid membranes (mechanism under characterization)

External Resources

    Related Other Compounds

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.